Cerebral Venous Thrombosis Studies

1.  Thrombolysis or Anticoagulation for Cerebral Venous Thrombosis (TOACT)

Prospective, randomized, multicenter, open-label trial to determine if endovascular thrombolysis improves the functional outcome of patients with severe cerebral venous sinus thrombosis compared to systemic anticoagulation. Study sponsor is Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). This study is currently recruiting participants.